TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

FINASTERIDE

FINASTERIDE
Approved 2006-06-19
Jump to: Indications Approvals Trials Competitors Safety Patents
17
Indications
--
Phase 3 Trials
19
Years on Market

Details

Status
Discontinued
First Approved
2006-06-19
Routes
ORAL
Dosage Forms
TABLET

Companies

Cipla HETERO LABS LTD III Dr. Reddy's NATCO PHARMA Teva IVAX SUB TEVA PHARMS Aurobindo Pharma ZYDUS PHARMS USA INC ALKEM LABS LTD GEDEON RICHTER USA Viatris Sun Pharma ACCORD HLTHCARE
Active Ingredient: FINASTERIDE

FINASTERIDE Approval History

Loading approval history...

What FINASTERIDE Treats

17 FDA approvals

Originally approved for its first indication in 2006 . Covers 17 distinct patient populations.

  • Other (17)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

FINASTERIDE FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA077335 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.